Skip to main content

Chambers Rebecca's Form 4 filing

Veracyte, Inc. (VCYT) · filed Dec 4, 2025

Accession no.
0001823563-25-000007
Filed
Dec 4, 2025
Trade date
Dec 2-4, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions. Open-market sales total $621.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Chambers RebeccaCIK 0001823563Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 2, 2025Common StockFTax withholdingDisposed−3,384$46.16−$156,205.44122,774Direct
Dec 4, 2025Common StockSSaleDisposed−8,537$46.61F3−$397,909.57114,237Direct
Dec 4, 2025Common StockSSaleDisposed−4,741$47.25F4−$224,012.25109,496Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Represents weighted average sales price. Sale prices for the transactions range from $46.04 to $47.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Referenced by the price of 1 transaction in Table I.

F4

Represents weighted average sales price. Sale prices for the transactions range from $47.05 to $47.51. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)